Stocks and Investing Stocks and Investing
Tue, October 5, 2021

Christopher Raymond Maintained (BHVN) at Buy with Increased Target to $156 on, Oct 5th, 2021


Published on 2024-10-27 18:03:36 - WOPRAI, Christopher Raymond
  Print publication without navigation


Christopher Raymond of Piper Sandler, Maintained "Biohaven Ltd." (BHVN) at Buy with Increased Target from $140 to $156 on, Oct 5th, 2021.

Christopher has made no other calls on BHVN in the last 4 months.



There are 6 other peers that have a rating on BHVN. Out of the 6 peers that are also analyzing BHVN, 2 agree with Christopher's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Esther Rajavelu of "UBS" Downgraded from Strong Buy to Hold and Increased Target to $109 on, Tuesday, August 10th, 2021
  • Matthew Harrison of "Morgan Stanley" Maintained at Hold with Increased Target to $107 on, Friday, July 16th, 2021


These are the ratings of the 4 analyists that currently disagree with Christopher


  • Charles Duncan of "Cantor Fitzgerald" Maintained at Buy with Increased Target to $165 on, Monday, September 13th, 2021
  • Sumant Kulkarni of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $150 on, Tuesday, August 3rd, 2021
  • Vamil Divan of "Mizuho" Maintained at Strong Buy with Increased Target to $134 on, Monday, July 12th, 2021
  • Douglas Tsao of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $135 on, Thursday, July 8th, 2021
Contributing Sources